Alexion Pharmaceuticals, Inc.
Compositions and methods for treating craniosynostosis
Last updated:
Abstract:
Provided herein are compositions and methods for treating craniosynostosis. In particular, provided herein are methods of treating and preventing craniosynostosis by administering an isolated TNAP polypeptide or a nucleic acid molecule that encodes a TNAP polypeptide.
Status:
Grant
Type:
Utility
Filling date:
10 Jul 2015
Issue date:
3 Nov 2020